Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Berger

Showing results (691-700 of 724) with videos related to

Pageof 73
Sort By:
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|May 13, 2024
Transport of dust across the Solar System: Constraints on the spatial origin of individual micrometeorites from cosmic-ray exposureJ Feige, A Airo, D Berger, et al.
Frontiers in Neurology|October 16, 2023
Transient ischemic attacks in patients with active and occult cancerMorin Beyeler, Pasquale Castigliego, Joel Baumann, et al.
Frontiers in Physiology|September 14, 2018
The Fibrotic Substrate in Persistent Atrial Fibrillation Patients: Comparison Between Predictions From Computational Modeling and Measurements From Focal Impulse and Rotor MappingPatrick M Boyle, Joe B Hakim, Sohail Zahid, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 26, 2022
Development of a Score for Prediction of Occult Malignancy in Stroke Patients (Occult-5 Score)Morin Beyeler, Barbara Birner, Mattia Branca, et al.
Molecular Cancer Therapeutics|May 20, 2016
Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus BevacizumabSatoshi Okazaki, Fotios Loupakis, Sebastian Stintzing, et al.
The Pharmacogenomics Journal|August 10, 2016
CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapyS Matsusaka, S Cao, D L Hanna, et al.
The Journal of Clinical Investigation|December 20, 2000
Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in miceM P Lee, J D Ravenel, R J Hu, et al.
IJTLD Open|May 14, 2025
Evaluating disability, comorbidities and risk factors after TB treatment: an 18-24 month follow-upY Sun, Y Lin, J E Golub, et al.
International Journal of Cancer|March 12, 2019
AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3Ryuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2019
Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal CancerRyuma Tokunaga, Joanne Xiu, Curtis Johnston, et al.
Pageof 73

Showing results (691-700 of 724) with videos related to

Sort By:
Pageof 73
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|May 13, 2024
Transport of dust across the Solar System: Constraints on the spatial origin of individual micrometeorites from cosmic-ray exposureJ Feige, A Airo, D Berger, et al.
Frontiers in Neurology|October 16, 2023
Transient ischemic attacks in patients with active and occult cancerMorin Beyeler, Pasquale Castigliego, Joel Baumann, et al.
Frontiers in Physiology|September 14, 2018
The Fibrotic Substrate in Persistent Atrial Fibrillation Patients: Comparison Between Predictions From Computational Modeling and Measurements From Focal Impulse and Rotor MappingPatrick M Boyle, Joe B Hakim, Sohail Zahid, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 26, 2022
Development of a Score for Prediction of Occult Malignancy in Stroke Patients (Occult-5 Score)Morin Beyeler, Barbara Birner, Mattia Branca, et al.
Molecular Cancer Therapeutics|May 20, 2016
Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus BevacizumabSatoshi Okazaki, Fotios Loupakis, Sebastian Stintzing, et al.
The Pharmacogenomics Journal|August 10, 2016
CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapyS Matsusaka, S Cao, D L Hanna, et al.
The Journal of Clinical Investigation|December 20, 2000
Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in miceM P Lee, J D Ravenel, R J Hu, et al.
IJTLD Open|May 14, 2025
Evaluating disability, comorbidities and risk factors after TB treatment: an 18-24 month follow-upY Sun, Y Lin, J E Golub, et al.
International Journal of Cancer|March 12, 2019
AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3Ryuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2019
Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal CancerRyuma Tokunaga, Joanne Xiu, Curtis Johnston, et al.
Pageof 73